You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(1530.HK)繼續拉昇 最近1個月累漲超60%
格隆匯 06-18 10:25
格隆匯6月18日丨繼昨日收漲5.15%後,三生製藥(1530.HK)今日繼續拉昇,盤中一度再漲超10%報11.48港元,股價創去年7月以來新高,市值超290億港元。該股自5月中旬反彈至今,1個多月期間累漲超60%。據悉,三生製藥為高瓴概念股,高瓴目前持有2.29億股,佔公司總股本的9.04%。有分析人士指出,高瓴主要看中其創新藥方面的研發能力。三生製藥的研發管線非常紮實,目前共有34項在研產品,24項為一類新藥。34項在研產品中,19項為單抗或雙特異性抗體,6項為其他生物製品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account